Trius To Present at Citi & RBC Investor Conferences
Trius Annouces Issuance of Tedizolid Patent in China
Trius to Present at the BIO CEO & Investor Conference
Genetic Environment and Stability of cfr in MRSA CM05, Locke et al.
In Vitro Activity of Tedizolid (TR-700) Against Linezolid-Resistant Staphylococci, Rodriguez-Avial et al.